NCT04224610

Brief Summary

The purpose of this study is to analyze the data of patients who underwent FFR evaluation at CAVHS to evaluate the impact of PCI on coronary hemodynamics in patients with baseline ischemic FFR, the potential etiologies of suboptimal FFR post PCI, determine potential measures taken to correct persistently suboptimal FFR and PCI, and determine rate of clinical events, utility of routine Post PCI FFR strategy compared to pre PCI FFR strategy only, and evaluate the "Warranty Period" of non-ischemic FFR in different sub groups.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
33mo left

Started Mar 2009

Longer than P75 for all trials

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Mar 2009Dec 2028

Study Start

First participant enrolled

March 1, 2009

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2015

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2019

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 13, 2020

Completed
9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Expected
Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

6.1 years

First QC Date

August 12, 2019

Last Update Submit

February 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Impact of PCI

    • Evaluate the impact of PCI on coronary hemodynamics in patients with baseline ischemic FFR compared to final FFR

    Immediately post procedure

Secondary Outcomes (5)

  • Potential etiologies of suboptimal FFR

    Immediately post procedure

  • Determine potential corrective measures

    Immediately post procedure

  • Determine rate of clinical events

    Immediately post procedure

  • Compare post PCI FFR strategy to pre PCI FFR only

    Immediately post procedure

  • Evaluate "Warranty Period"

    Through end of study, approximately 5 years

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients that have undergone FFR at CAVHS between 3/2009 and 3/2015 will be reviewed. Comparison of baseline, angiographic, procedural and outcome variables for patients with FFR\>0.9 and \<0.9 will be done using unpaired Student's t-test for continuous variables and the chi square test( χ2 ) for categorical or dichotomous variables. Unadjusted annual event rates for those with and without FFR\>0.9 will be calculated by first estimating overall event rates for these groups through calculation of Kaplan-Meier(K-M) curves, then dividing the event rate by the mean follow-up time for each of the groups. Additionally, median pre and post FFR, (%) diameter stenosis will be calculated for patients with and without clinical outcomes.Univariate predictors of post PCI, FFR,and MACE will recorded.

You may qualify if:

  • Patients that have undergone FFR at CAVHS between 3/2009 and 3/2015.

You may not qualify if:

  • No FFR

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (8)

  • Lotfi A, Jeremias A, Fearon WF, Feldman MD, Mehran R, Messenger JC, Grines CL, Dean LS, Kern MJ, Klein LW; Society of Cardiovascular Angiography and Interventions. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):509-18. doi: 10.1002/ccd.25222. Epub 2013 Nov 13. No abstract available.

    PMID: 24227282BACKGROUND
  • Hanekamp CE, Koolen JJ, Pijls NH, Michels HR, Bonnier HJ. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 1999 Mar 2;99(8):1015-21. doi: 10.1161/01.cir.99.8.1015.

    PMID: 10051294BACKGROUND
  • Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B; Fractional Flow Reserve (FFR) Post-Stent Registry Investigators. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002 Jun 25;105(25):2950-4. doi: 10.1161/01.cir.0000020547.92091.76.

    PMID: 12081986BACKGROUND
  • Fearon WF, Luna J, Samady H, Powers ER, Feldman T, Dib N, Tuzcu EM, Cleman MW, Chou TM, Cohen DJ, Ragosta M, Takagi A, Jeremias A, Fitzgerald PJ, Yeung AC, Kern MJ, Yock PG. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation. 2001 Oct 16;104(16):1917-22. doi: 10.1161/hc4101.097539.

    PMID: 11602494BACKGROUND
  • Bech GJ, Pijls NH, De Bruyne B, Peels KH, Michels HR, Bonnier HJ, Koolen JJ. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation. 1999 Feb 23;99(7):883-8. doi: 10.1161/01.cir.99.7.883.

    PMID: 10027810BACKGROUND
  • Klauss V, Erdin P, Rieber J, Leibig M, Stempfle HU, Konig A, Baylacher M, Theisen K, Haufe MC, Sroczynski G, Schiele T, Siebert U. Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis. Heart. 2005 Feb;91(2):203-6. doi: 10.1136/hrt.2003.027797.

    PMID: 15657233BACKGROUND
  • Leesar MA, Satran A, Yalamanchili V, Helmy T, Abdul-Waheed M, Wongpraparut N. The impact of fractional flow reserve measurement on clinical outcomes after transradial coronary stenting. EuroIntervention. 2011 Dec;7(8):917-23. doi: 10.4244/EIJV7I8A145.

    PMID: 22157476BACKGROUND
  • Dupouy P, Gilard M, Morelle JF, Furber A, Aptecar E, Cazaux P, Slama M, Feldman LJ, Wittenberg O, Pernes JM, Huret B, Commeau P, Boschat J, Teiger E, Lafont A, Steg PG, Dubois Rande JL. Usefulness and clinical impact of a fractional flow reserve and angiographic targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registry. EuroIntervention. 2005 May;1(1):85-92.

    PMID: 19758882BACKGROUND

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Barry Uretsky, MD

    CAVHS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2019

First Posted

January 13, 2020

Study Start

March 1, 2009

Primary Completion

March 31, 2015

Study Completion (Estimated)

December 31, 2028

Last Updated

February 17, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share